Oxygen radicals and protein kinase C (PKC) mediate ischemic preconditioning. Using a cultured chick embryonic cardiomyocyte model of hypoxia and reoxygenation, we found that the oxygen radicals generated by ischemic preconditioning were H 2O2. Like preconditioning, H 2O2 selectively activated the ⑀-isoform of PKC in the particulate compartment and increased cell viability after 1 h of hypoxia and 3 h of reoxygenation. The glutathione peroxidase ebselen (converting H 2O2 to H2O) and the superoxide dismutase inhibitor diethyldithiocarbamic acid abolished the increased H 2O2 and the protection of preconditioning. PKC activation with phorbol 12-myristate 13-acetate increased cell survival; the protection of preconditioning was blocked by ⑀V 1-2, a selective PKC-⑀ antagonist. Similar to preconditioning, the protection of PKC activation was abolished by mitochondrial K ATP channel blockade with 5-hydroxydecanoate or by GABA receptor stimulation with midazolam or diazepam. In addition, PKC, mitochondrial ATP-sensitive K ϩ (KATP) channels, and GABA receptors had no effects on H 2O2 generated by ischemic preconditioning before prolonged hypoxia and reoxygenation. We conclude that H 2O2 opens mitochondrial KATP channels and inhibits GABA receptors via activating PKC-⑀. Through this signal transduction, preconditioning protects ischemic cardiomyocytes.␥-aminobutyric acid receptors; preconditioning OXYGEN RADICALS are important intracellular second messengers that mediate cardioprotection (7, 9). Preconditioning and flumazenil generate oxygen radicals and protect cardiomyocytes during ischemia-reperfusion (42). Flumazenil inhibits the GABA receptor complex (20). The GABA receptor antagonist is used clinically for reversal of apnea and loss of consciousness associated with oversedation (2) and might be beneficial in protecting against cerebral ischemia (20). Rapid administration of a GABA complex antagonist produces minimal coronary and left ventricular hemodynamic responses (24). GABA receptor antagonists might have a role in the management of patients with ischemic heart disease if they can mimic preconditioning to protect the heart and thus have cardiac protective properties. The first objective of our study was to examine the role of GABA receptors in the development of preconditioning protection.GABA receptors have been identified in mitochondria (2,19,27,28). Reactive oxygen species originating from mitochondria, ATP-sensitive K ϩ (K ATP ) channels, and protein kinase C (PKC) are second messengers in cardioprotection produced by hypoxic preconditioning, acetylcholine, opioids, and flumazenil (25,31,34,37,38). A second objective of this study was to examine the role of GABA receptors on preconditioning-induced oxygen radicals before the start of ischemia and to determine the sequence of GABA receptors, PKC, and oxygen radicals in the signal transduction pathway of ischemic preconditioning.Cardiocyte injury in ischemia-reperfusion models correlates with the amount of free radicals produced (33), especially during the fir...